PIEZO1 and liver disorder: Future research should validate Piezo1-targeted modulators in appropriate models, uncover tissue-specific regulatory mechanisms of Piezo1 activity, and develop effective therapeutic delivery approaches to leverage Piezo1 as a possible clinical target in liver disease.